Update on therapeutic options for multiple sclerosis.

Matthew McCoyd

Journal: Neurologic clinics 2014;31(3):827-45

PMID: 23896508

Full Text on Elsevier Science View on PubMed

Abstract

Multiple sclerosis (MS) is one of the most common neurologic disorders that affects young people. The disorder has long been associated with clinical relapses and a disabling course. However, there has been a rapid expansion in the available treatment options for MS, and new insights into existing therapies, as decades of research has begun to produce tangible treatment results leading to newly approved an emerging therapies.

Address: Loyola University Medical Center, Building 105, Room 2700, 2160 South First Avenue, Maywood, IL 60153, USA. [email protected]

DOI: 10.1016/j.ncl.2013.03.010

Link outs

Free resources

Medical:

https://medlineplus.gov/multiplesclerosis.html

Other Literature Sources:

https://scite.ai/reports/23896508

Subscription / membership required

Full Text Sources:

MeSH Terms: Choice Behavior, Humans, Immunologic Factors, Multiple Sclerosis